

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.03803239 |
| 2 | response to pheromone (GO:0019236) | 3.94652686 |
| 3 | fibrinolysis (GO:0042730) | 3.92758718 |
| 4 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.84002148 |
| 5 | negative regulation of fibrinolysis (GO:0051918) | 3.79749880 |
| 6 | plasma membrane repair (GO:0001778) | 3.65018823 |
| 7 | cell communication by electrical coupling (GO:0010644) | 3.63519642 |
| 8 | regulation of synapse structural plasticity (GO:0051823) | 3.60014768 |
| 9 | cell communication involved in cardiac conduction (GO:0086065) | 3.58061812 |
| 10 | nucleobase catabolic process (GO:0046113) | 3.56114269 |
| 11 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.55940249 |
| 12 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.53796745 |
| 13 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.52780442 |
| 14 | regulation of plasminogen activation (GO:0010755) | 3.50326010 |
| 15 | vocalization behavior (GO:0071625) | 3.48258235 |
| 16 | blood coagulation, intrinsic pathway (GO:0007597) | 3.42223537 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.41363607 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.41149174 |
| 19 | protein carboxylation (GO:0018214) | 3.41149174 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.39323267 |
| 21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.37768428 |
| 22 | platelet degranulation (GO:0002576) | 3.37579051 |
| 23 | cell-substrate junction assembly (GO:0007044) | 3.36967228 |
| 24 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.33163892 |
| 25 | fatty acid transmembrane transport (GO:1902001) | 3.33073656 |
| 26 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.29085526 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.28682006 |
| 28 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.27184628 |
| 29 | synaptic vesicle maturation (GO:0016188) | 3.26493704 |
| 30 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.26408058 |
| 31 | cell adhesion mediated by integrin (GO:0033627) | 3.26307698 |
| 32 | positive regulation of hemostasis (GO:1900048) | 3.26037114 |
| 33 | positive regulation of blood coagulation (GO:0030194) | 3.26037114 |
| 34 | locomotory exploration behavior (GO:0035641) | 3.25250215 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.24512823 |
| 36 | regulation of fibrinolysis (GO:0051917) | 3.22803989 |
| 37 | extracellular fibril organization (GO:0043206) | 3.22585318 |
| 38 | negative regulation of protein localization to cell surface (GO:2000009) | 3.19441251 |
| 39 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.17815466 |
| 40 | carnitine shuttle (GO:0006853) | 3.17181410 |
| 41 | barbed-end actin filament capping (GO:0051016) | 3.15062785 |
| 42 | negative regulation of hemostasis (GO:1900047) | 3.14145476 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 3.14145476 |
| 44 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.12193323 |
| 45 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09546656 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.05817049 |
| 47 | establishment of nucleus localization (GO:0040023) | 3.05030106 |
| 48 | cardiac myofibril assembly (GO:0055003) | 3.04699821 |
| 49 | positive regulation of receptor recycling (GO:0001921) | 3.04686803 |
| 50 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.03811079 |
| 51 | triglyceride catabolic process (GO:0019433) | 3.03100386 |
| 52 | negative regulation of coagulation (GO:0050819) | 3.01318694 |
| 53 | positive regulation of coagulation (GO:0050820) | 3.01138798 |
| 54 | stress fiber assembly (GO:0043149) | 2.97885348 |
| 55 | hemidesmosome assembly (GO:0031581) | 2.96961893 |
| 56 | protein localization to endosome (GO:0036010) | 2.95058110 |
| 57 | dendrite morphogenesis (GO:0048813) | 2.93928935 |
| 58 | gamma-aminobutyric acid transport (GO:0015812) | 2.93249354 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.92830455 |
| 60 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.92822779 |
| 61 | regulation of lipoprotein metabolic process (GO:0050746) | 2.92651249 |
| 62 | L-phenylalanine metabolic process (GO:0006558) | 2.92546673 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.92546673 |
| 64 | sarcomere organization (GO:0045214) | 2.92261212 |
| 65 | negative regulation of wound healing (GO:0061045) | 2.91551072 |
| 66 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.91505690 |
| 67 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90979893 |
| 68 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.89569911 |
| 69 | regulation of membrane repolarization (GO:0060306) | 2.89330338 |
| 70 | glutamate secretion (GO:0014047) | 2.88453179 |
| 71 | protein heterotrimerization (GO:0070208) | 2.87223283 |
| 72 | positive regulation of wound healing (GO:0090303) | 2.86505831 |
| 73 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.86240322 |
| 74 | cell migration in hindbrain (GO:0021535) | 2.85948837 |
| 75 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.84813762 |
| 76 | proline transport (GO:0015824) | 2.84515459 |
| 77 | negative regulation of platelet activation (GO:0010544) | 2.84111147 |
| 78 | acylglycerol catabolic process (GO:0046464) | 2.81527122 |
| 79 | neutral lipid catabolic process (GO:0046461) | 2.81527122 |
| 80 | regulation of cell communication by electrical coupling (GO:0010649) | 2.80662980 |
| 81 | endodermal cell differentiation (GO:0035987) | 2.80586876 |
| 82 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.79179246 |
| 83 | synaptic vesicle exocytosis (GO:0016079) | 2.78597105 |
| 84 | angiogenesis involved in wound healing (GO:0060055) | 2.76172933 |
| 85 | fibril organization (GO:0097435) | 2.75567309 |
| 86 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.74140968 |
| 87 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.73995976 |
| 88 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.71289252 |
| 89 | cardiac muscle contraction (GO:0060048) | 2.68739468 |
| 90 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.68504452 |
| 91 | regulation of protein activation cascade (GO:2000257) | 2.67791030 |
| 92 | skin morphogenesis (GO:0043589) | 2.67704809 |
| 93 | focal adhesion assembly (GO:0048041) | 2.66989947 |
| 94 | cell-substrate adherens junction assembly (GO:0007045) | 2.66989947 |
| 95 | adherens junction assembly (GO:0034333) | 2.66874509 |
| 96 | cellular ketone body metabolic process (GO:0046950) | 2.65830010 |
| 97 | low-density lipoprotein particle clearance (GO:0034383) | 2.64922303 |
| 98 | cellular potassium ion homeostasis (GO:0030007) | 2.64542917 |
| 99 | basement membrane organization (GO:0071711) | 2.63792872 |
| 100 | positive regulation of synapse maturation (GO:0090129) | 2.63163767 |
| 101 | sodium ion export (GO:0071436) | 2.63056419 |
| 102 | actin-mediated cell contraction (GO:0070252) | 2.62252660 |
| 103 | tricarboxylic acid cycle (GO:0006099) | 2.60650304 |
| 104 | cerebellar granule cell differentiation (GO:0021707) | 2.60453279 |
| 105 | lysine catabolic process (GO:0006554) | 2.60337365 |
| 106 | lysine metabolic process (GO:0006553) | 2.60337365 |
| 107 | neuron recognition (GO:0008038) | 2.60223634 |
| 108 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.59563522 |
| 109 | complement activation, alternative pathway (GO:0006957) | 2.59514563 |
| 110 | regulation of complement activation (GO:0030449) | 2.59303774 |
| 111 | myofibril assembly (GO:0030239) | 2.58410428 |
| 112 | platelet aggregation (GO:0070527) | 2.58397601 |
| 113 | dendritic spine morphogenesis (GO:0060997) | 2.56930675 |
| 114 | exploration behavior (GO:0035640) | 2.56267406 |
| 115 | neurotransmitter secretion (GO:0007269) | 2.56169678 |
| 116 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.55455383 |
| 117 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.54523501 |
| 118 | protein localization to synapse (GO:0035418) | 2.53841189 |
| 119 | mesodermal cell differentiation (GO:0048333) | 2.53651565 |
| 120 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53514779 |
| 121 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.51356786 |
| 122 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.51356786 |
| 123 | hypotonic response (GO:0006971) | 2.50920340 |
| 124 | regulation of axon guidance (GO:1902667) | 2.50760799 |
| 125 | membrane raft organization (GO:0031579) | 2.50629764 |
| 126 | axon extension (GO:0048675) | 2.49949801 |
| 127 | 2-oxoglutarate metabolic process (GO:0006103) | 2.49673700 |
| 128 | regulation of blood coagulation (GO:0030193) | 2.48956957 |
| 129 | regulation of hemostasis (GO:1900046) | 2.48956957 |
| 130 | protein targeting to plasma membrane (GO:0072661) | 2.48614905 |
| 131 | membrane depolarization during action potential (GO:0086010) | 2.48479972 |
| 132 | neuron cell-cell adhesion (GO:0007158) | 2.46469339 |
| 133 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.44623761 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 2.44230417 |
| 135 | axonal fasciculation (GO:0007413) | 2.43503840 |
| 136 | substrate-dependent cell migration (GO:0006929) | 2.42130892 |
| 137 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.41822165 |
| 138 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.41627252 |
| 139 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.41540097 |
| 140 | regulation of actin filament-based movement (GO:1903115) | 2.40651581 |
| 141 | carnitine transmembrane transport (GO:1902603) | 2.40105046 |
| 142 | cell-matrix adhesion (GO:0007160) | 2.39769105 |
| 143 | positive regulation of axon extension (GO:0045773) | 2.39132112 |
| 144 | regulation of coagulation (GO:0050818) | 2.39012902 |
| 145 | glutamate receptor signaling pathway (GO:0007215) | 2.38856974 |
| 146 | cellular response to epinephrine stimulus (GO:0071872) | 2.38531579 |
| 147 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.38153229 |
| 148 | regulation of fatty acid oxidation (GO:0046320) | 2.37944712 |
| 149 | regulation of sequestering of triglyceride (GO:0010889) | 2.36567058 |
| 150 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.36496448 |
| 151 | cell migration involved in heart development (GO:0060973) | 2.36169115 |
| 152 | extracellular matrix assembly (GO:0085029) | 2.35355426 |
| 153 | synaptic transmission, glutamatergic (GO:0035249) | 2.35006544 |
| 154 | actin filament depolymerization (GO:0030042) | 2.33592507 |
| 155 | regulation of early endosome to late endosome transport (GO:2000641) | 2.33067185 |
| 156 | regulation of the force of heart contraction (GO:0002026) | 2.31980807 |
| 157 | epithelial cell-cell adhesion (GO:0090136) | 2.31886399 |
| 158 | regulation of synaptic vesicle transport (GO:1902803) | 2.31126197 |
| 159 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.30688801 |
| 160 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.30688801 |
| 161 | cardiac conduction (GO:0061337) | 2.30590164 |
| 162 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.29032765 |
| 163 | regulation of metalloenzyme activity (GO:0048552) | 2.28121747 |
| 164 | muscle filament sliding (GO:0030049) | 2.28004123 |
| 165 | actin-myosin filament sliding (GO:0033275) | 2.28004123 |
| 166 | regulation of wound healing (GO:0061041) | 2.26978470 |
| 167 | alanine transport (GO:0032328) | 2.25942176 |
| 168 | acetyl-CoA metabolic process (GO:0006084) | 2.25684963 |
| 169 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.25630451 |
| 170 | muscle cell migration (GO:0014812) | 2.25270526 |
| 171 | ketone body metabolic process (GO:1902224) | 2.25214203 |
| 172 | potassium ion import (GO:0010107) | 2.25158959 |
| 173 | L-phenylalanine catabolic process (GO:0006559) | 2.24499014 |
| 174 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.24499014 |
| 175 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.24452024 |
| 176 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.24412053 |
| 177 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.23434157 |
| 178 | negative regulation of potassium ion transport (GO:0043267) | 2.23043075 |
| 179 | regulation of relaxation of muscle (GO:1901077) | 2.22484749 |
| 180 | amino-acid betaine transport (GO:0015838) | 2.22053126 |
| 181 | negative regulation of adherens junction organization (GO:1903392) | 2.22001519 |
| 182 | negative regulation of focal adhesion assembly (GO:0051895) | 2.22001519 |
| 183 | negative regulation of cell junction assembly (GO:1901889) | 2.22001519 |
| 184 | protein localization to cell surface (GO:0034394) | 2.21729131 |
| 185 | endocytic recycling (GO:0032456) | 2.21502546 |
| 186 | desmosome organization (GO:0002934) | 2.20934681 |
| 187 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.18519142 |
| 188 | actin filament-based movement (GO:0030048) | 2.18512892 |
| 189 | endothelium development (GO:0003158) | 2.17762972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.84865781 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.95560750 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.14391447 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.89678614 |
| 5 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65940741 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.57021810 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.46774272 |
| 8 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.43974734 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.38067103 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.38067103 |
| 11 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.34678718 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.31649425 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.25845382 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25288547 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19310793 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13321958 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12140064 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.11664339 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.11587368 |
| 20 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11042534 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10746177 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05831600 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04137948 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.03124914 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99451803 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91794490 |
| 27 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.91613189 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88114519 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87783002 |
| 30 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.80749125 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.78567157 |
| 32 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77644192 |
| 33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69664071 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.69347317 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68818392 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.67186198 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65277912 |
| 38 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64681669 |
| 39 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62110678 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.61799900 |
| 41 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.58938973 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.58717558 |
| 43 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58166163 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57678454 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56916467 |
| 46 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.56824240 |
| 47 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.55914286 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55806785 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.55792881 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54595001 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.51855275 |
| 52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49969775 |
| 53 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46389935 |
| 54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46389935 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.44521688 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.44015440 |
| 57 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41015358 |
| 58 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37393971 |
| 59 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36789199 |
| 60 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36490231 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33327164 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32933680 |
| 63 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31801519 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30381266 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29594103 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28402213 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27993310 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.27818754 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25611465 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25611465 |
| 71 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25492125 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24815280 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24255913 |
| 74 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.24093395 |
| 75 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24023593 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23392644 |
| 77 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.19612621 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19590525 |
| 79 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.19493703 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19053194 |
| 81 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.16882644 |
| 82 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16799427 |
| 83 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.16605455 |
| 84 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.16324885 |
| 85 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.15672469 |
| 86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.15638173 |
| 87 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.15492242 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13780398 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13065780 |
| 90 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.12960241 |
| 91 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12601653 |
| 92 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12029758 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11718561 |
| 94 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.11325612 |
| 95 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09445502 |
| 96 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08589996 |
| 97 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.08362980 |
| 98 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08342292 |
| 99 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08327258 |
| 100 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.08153974 |
| 101 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.07498534 |
| 102 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06800202 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.06316257 |
| 104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05843819 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05834310 |
| 106 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05342431 |
| 107 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05122760 |
| 108 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04668609 |
| 109 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03818539 |
| 110 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03009716 |
| 111 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02850124 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02179522 |
| 113 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01892533 |
| 114 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01365250 |
| 115 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99957580 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99652213 |
| 117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98883681 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98611576 |
| 119 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98140724 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98072478 |
| 121 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97293128 |
| 122 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97133314 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97133314 |
| 124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96530301 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95694688 |
| 126 | AR_25329375_ChIP-Seq_VCAP_Human | 0.95117974 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94595918 |
| 128 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94519958 |
| 129 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.94315385 |
| 130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94124143 |
| 131 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93764209 |
| 132 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93147810 |
| 133 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92938830 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92497141 |
| 135 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92125821 |
| 136 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92065829 |
| 137 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91255590 |
| 138 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90755508 |
| 139 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90334829 |
| 140 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.90306430 |
| 141 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89255381 |
| 142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88505734 |
| 143 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87571550 |
| 144 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86943808 |
| 145 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86919201 |
| 146 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86810254 |
| 147 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86631583 |
| 148 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86510169 |
| 149 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86404164 |
| 150 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.86212369 |
| 151 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.85911422 |
| 152 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85539088 |
| 153 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85230669 |
| 154 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84950492 |
| 155 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82185057 |
| 156 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.82031658 |
| 157 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80348782 |
| 158 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79871393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.34799727 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 3.99513913 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.87759104 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.55162187 |
| 5 | MP0000751_myopathy | 3.43713204 |
| 6 | MP0003566_abnormal_cell_adhesion | 3.20515239 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.83916524 |
| 8 | MP0004215_abnormal_myocardial_fiber | 2.75022705 |
| 9 | MP0003950_abnormal_plasma_membrane | 2.74719078 |
| 10 | MP0003646_muscle_fatigue | 2.67778954 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.53812065 |
| 12 | MP0004130_abnormal_muscle_cell | 2.52430745 |
| 13 | MP0004270_analgesia | 2.50893722 |
| 14 | MP0003279_aneurysm | 2.33050699 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.32815522 |
| 16 | MP0005275_abnormal_skin_tensile | 2.32801211 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.18335236 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.17458615 |
| 19 | MP0001958_emphysema | 2.12505013 |
| 20 | MP0005360_urolithiasis | 2.08502575 |
| 21 | MP0003880_abnormal_central_pattern | 2.01300830 |
| 22 | MP0002063_abnormal_learning/memory/cond | 1.95012810 |
| 23 | MP0005023_abnormal_wound_healing | 1.91397309 |
| 24 | MP0003137_abnormal_impulse_conducting | 1.91378066 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.88904230 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.82517427 |
| 27 | MP0005330_cardiomyopathy | 1.79551175 |
| 28 | MP0003828_pulmonary_edema | 1.79531409 |
| 29 | MP0001968_abnormal_touch/_nociception | 1.78877134 |
| 30 | MP0003091_abnormal_cell_migration | 1.77939182 |
| 31 | MP0000749_muscle_degeneration | 1.77923293 |
| 32 | MP0009745_abnormal_behavioral_response | 1.73941316 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.73795134 |
| 34 | MP0005365_abnormal_bile_salt | 1.72992246 |
| 35 | MP0009046_muscle_twitch | 1.72524881 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.72069645 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.71824786 |
| 38 | MP0005085_abnormal_gallbladder_physiolo | 1.71070537 |
| 39 | MP0002734_abnormal_mechanical_nocicepti | 1.70993792 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.70535604 |
| 41 | MP0003329_amyloid_beta_deposits | 1.68899891 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.68707571 |
| 43 | MP0005620_abnormal_muscle_contractility | 1.66492563 |
| 44 | MP0004085_abnormal_heartbeat | 1.66185887 |
| 45 | MP0002972_abnormal_cardiac_muscle | 1.64945474 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.62065665 |
| 47 | MP0001440_abnormal_grooming_behavior | 1.60657889 |
| 48 | MP0005375_adipose_tissue_phenotype | 1.60218294 |
| 49 | MP0002064_seizures | 1.57617048 |
| 50 | MP0002909_abnormal_adrenal_gland | 1.56110206 |
| 51 | MP0006138_congestive_heart_failure | 1.53704876 |
| 52 | MP0005670_abnormal_white_adipose | 1.53105081 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.52536875 |
| 54 | MP0002572_abnormal_emotion/affect_behav | 1.51079956 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.46364133 |
| 56 | MP0004484_altered_response_of | 1.45529242 |
| 57 | MP0002184_abnormal_innervation | 1.45449333 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.44921749 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.44168876 |
| 60 | MP0000343_altered_response_to | 1.43478622 |
| 61 | MP0004858_abnormal_nervous_system | 1.42867559 |
| 62 | MP0005165_increased_susceptibility_to | 1.40860444 |
| 63 | MP0002272_abnormal_nervous_system | 1.40581173 |
| 64 | MP0000747_muscle_weakness | 1.39640979 |
| 65 | MP0000767_abnormal_smooth_muscle | 1.38495766 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.37872282 |
| 67 | MP0001542_abnormal_bone_strength | 1.37716058 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.37353276 |
| 69 | MP0009840_abnormal_foam_cell | 1.36643002 |
| 70 | MP0002295_abnormal_pulmonary_circulatio | 1.36464417 |
| 71 | MP0008004_abnormal_stomach_pH | 1.35844655 |
| 72 | MP0005385_cardiovascular_system_phenoty | 1.35192974 |
| 73 | MP0001544_abnormal_cardiovascular_syste | 1.35192974 |
| 74 | MP0002106_abnormal_muscle_physiology | 1.35079653 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.31868751 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.31336918 |
| 77 | MP0005595_abnormal_vascular_smooth | 1.30557992 |
| 78 | MP0002067_abnormal_sensory_capabilities | 1.29820586 |
| 79 | MP0002269_muscular_atrophy | 1.28993798 |
| 80 | MP0000759_abnormal_skeletal_muscle | 1.26252499 |
| 81 | MP0000750_abnormal_muscle_regeneration | 1.25436317 |
| 82 | MP0000778_abnormal_nervous_system | 1.24995960 |
| 83 | MP0008569_lethality_at_weaning | 1.22494906 |
| 84 | MP0005386_behavior/neurological_phenoty | 1.21684426 |
| 85 | MP0004924_abnormal_behavior | 1.21684426 |
| 86 | MP0005257_abnormal_intraocular_pressure | 1.20008355 |
| 87 | MP0003868_abnormal_feces_composition | 1.19414416 |
| 88 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19371047 |
| 89 | MP0001486_abnormal_startle_reflex | 1.18562142 |
| 90 | MP0001970_abnormal_pain_threshold | 1.17941145 |
| 91 | MP0002736_abnormal_nociception_after | 1.16866912 |
| 92 | MP0002332_abnormal_exercise_endurance | 1.15587385 |
| 93 | MP0005409_darkened_coat_color | 1.15287646 |
| 94 | MP0005083_abnormal_biliary_tract | 1.13183632 |
| 95 | MP0003122_maternal_imprinting | 1.11760949 |
| 96 | MP0005666_abnormal_adipose_tissue | 1.10660237 |
| 97 | MP0004233_abnormal_muscle_weight | 1.10528101 |
| 98 | MP0005164_abnormal_response_to | 1.10495085 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 1.09655153 |
| 100 | MP0005369_muscle_phenotype | 1.08142596 |
| 101 | MP0005535_abnormal_body_temperature | 1.07679398 |
| 102 | MP0000733_abnormal_muscle_development | 1.06390860 |
| 103 | MP0005167_abnormal_blood-brain_barrier | 1.05648703 |
| 104 | MP0010630_abnormal_cardiac_muscle | 1.04979749 |
| 105 | MP0002108_abnormal_muscle_morphology | 1.03336730 |
| 106 | MP0000249_abnormal_blood_vessel | 1.02903385 |
| 107 | MP0002060_abnormal_skin_morphology | 1.02592108 |
| 108 | MP0001502_abnormal_circadian_rhythm | 1.01508550 |
| 109 | MP0004811_abnormal_neuron_physiology | 0.98304545 |
| 110 | MP0002557_abnormal_social/conspecific_i | 0.98127645 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.98016929 |
| 112 | MP0002896_abnormal_bone_mineralization | 0.96711502 |
| 113 | MP0000013_abnormal_adipose_tissue | 0.95874149 |
| 114 | MP0003252_abnormal_bile_duct | 0.95680579 |
| 115 | MP0000955_abnormal_spinal_cord | 0.95538970 |
| 116 | MP0002128_abnormal_blood_circulation | 0.95527598 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.94760926 |
| 118 | MP0004510_myositis | 0.93062874 |
| 119 | MP0005058_abnormal_lysosome_morphology | 0.91342242 |
| 120 | MP0005187_abnormal_penis_morphology | 0.91242462 |
| 121 | MP0001661_extended_life_span | 0.90843466 |
| 122 | MP0001984_abnormal_olfaction | 0.90765218 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.89650026 |
| 124 | MP0000858_altered_metastatic_potential | 0.89364858 |
| 125 | MP0002822_catalepsy | 0.88702795 |
| 126 | MP0002971_abnormal_brown_adipose | 0.88613828 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.87045826 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.84550029 |
| 129 | MP0004272_abnormal_basement_membrane | 0.83939035 |
| 130 | MP0005451_abnormal_body_composition | 0.83694980 |
| 131 | MP0003633_abnormal_nervous_system | 0.83424856 |
| 132 | MP0009053_abnormal_anal_canal | 0.82468039 |
| 133 | MP0003075_altered_response_to | 0.81838905 |
| 134 | MP0003879_abnormal_hair_cell | 0.81630933 |
| 135 | MP0005332_abnormal_amino_acid | 0.81137296 |
| 136 | MP0000604_amyloidosis | 0.80540345 |
| 137 | MP0002882_abnormal_neuron_morphology | 0.78867347 |
| 138 | MP0008874_decreased_physiological_sensi | 0.78793952 |
| 139 | MP0001849_ear_inflammation | 0.78769840 |
| 140 | MP0001915_intracranial_hemorrhage | 0.78495489 |
| 141 | MP0003690_abnormal_glial_cell | 0.78473906 |
| 142 | MP0004147_increased_porphyrin_level | 0.77870767 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.75005108 |
| 144 | MP0000762_abnormal_tongue_morphology | 0.73721521 |
| 145 | MP0003453_abnormal_keratinocyte_physiol | 0.73347546 |
| 146 | MP0004185_abnormal_adipocyte_glucose | 0.71775351 |
| 147 | MP0001299_abnormal_eye_distance/ | 0.68872850 |
| 148 | MP0000467_abnormal_esophagus_morphology | 0.67970815 |
| 149 | MP0001614_abnormal_blood_vessel | 0.67677915 |
| 150 | MP0004883_abnormal_blood_vessel | 0.67271617 |
| 151 | MP0003941_abnormal_skin_development | 0.66681339 |
| 152 | MP0006054_spinal_hemorrhage | 0.65599212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.77104779 |
| 2 | Protrusio acetabuli (HP:0003179) | 4.69584523 |
| 3 | Menorrhagia (HP:0000132) | 4.27610911 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.19554788 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.12290167 |
| 6 | Increased mean platelet volume (HP:0011877) | 4.08393614 |
| 7 | Myokymia (HP:0002411) | 3.94597014 |
| 8 | Abnormal platelet volume (HP:0011876) | 3.65982756 |
| 9 | Difficulty running (HP:0009046) | 3.56241882 |
| 10 | Aortic aneurysm (HP:0004942) | 3.55843540 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.48684612 |
| 12 | Distal lower limb muscle weakness (HP:0009053) | 3.46172997 |
| 13 | Calf muscle hypertrophy (HP:0008981) | 3.45047847 |
| 14 | Spinal rigidity (HP:0003306) | 3.41713580 |
| 15 | Myotonia (HP:0002486) | 3.38121282 |
| 16 | Focal motor seizures (HP:0011153) | 3.30104953 |
| 17 | Atrial fibrillation (HP:0005110) | 3.28045762 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.24854433 |
| 19 | Distal lower limb amyotrophy (HP:0008944) | 3.23204353 |
| 20 | Vascular tortuosity (HP:0004948) | 3.21965215 |
| 21 | Primary atrial arrhythmia (HP:0001692) | 3.20008330 |
| 22 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.18376619 |
| 23 | Ventricular fibrillation (HP:0001663) | 3.14902823 |
| 24 | Ventricular tachycardia (HP:0004756) | 3.10476417 |
| 25 | Action tremor (HP:0002345) | 3.10065090 |
| 26 | Visual hallucinations (HP:0002367) | 3.09658141 |
| 27 | Bundle branch block (HP:0011710) | 3.09213070 |
| 28 | Prolonged QT interval (HP:0001657) | 3.07646090 |
| 29 | Syncope (HP:0001279) | 3.05250791 |
| 30 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.03651648 |
| 31 | Aortic dissection (HP:0002647) | 3.02250765 |
| 32 | Supraventricular tachycardia (HP:0004755) | 3.00651322 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 2.99620731 |
| 34 | Nemaline bodies (HP:0003798) | 2.98538982 |
| 35 | Abnormality of the lower motor neuron (HP:0002366) | 2.98534664 |
| 36 | Arterial tortuosity (HP:0005116) | 2.95981253 |
| 37 | Abnormality of the calf musculature (HP:0001430) | 2.95565566 |
| 38 | Focal seizures (HP:0007359) | 2.91760948 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.85783778 |
| 40 | Joint hemorrhage (HP:0005261) | 2.85307977 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.85128212 |
| 42 | Purpura (HP:0000979) | 2.84908766 |
| 43 | Right ventricular cardiomyopathy (HP:0011663) | 2.82137713 |
| 44 | Ankle contracture (HP:0006466) | 2.81069232 |
| 45 | Myoglobinuria (HP:0002913) | 2.80417845 |
| 46 | Progressive cerebellar ataxia (HP:0002073) | 2.78476604 |
| 47 | Exercise-induced muscle cramps (HP:0003710) | 2.76598835 |
| 48 | Abnormality of complement system (HP:0005339) | 2.74020050 |
| 49 | Atrophic scars (HP:0001075) | 2.72207590 |
| 50 | Lower limb amyotrophy (HP:0007210) | 2.70583302 |
| 51 | Round ear (HP:0100830) | 2.67845762 |
| 52 | Mitral stenosis (HP:0001718) | 2.66793144 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64868149 |
| 54 | EMG: myopathic abnormalities (HP:0003458) | 2.62618693 |
| 55 | Ventricular arrhythmia (HP:0004308) | 2.57411609 |
| 56 | Abnormality of the Achilles tendon (HP:0005109) | 2.55142183 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.54727389 |
| 58 | Atrioventricular block (HP:0001678) | 2.53839264 |
| 59 | Increased connective tissue (HP:0009025) | 2.51447949 |
| 60 | Heart block (HP:0012722) | 2.50331669 |
| 61 | Abnormal EKG (HP:0003115) | 2.49432990 |
| 62 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48477347 |
| 63 | Polyphagia (HP:0002591) | 2.48264836 |
| 64 | Poor eye contact (HP:0000817) | 2.45500658 |
| 65 | Dysmetric saccades (HP:0000641) | 2.45448686 |
| 66 | Wormian bones (HP:0002645) | 2.45211237 |
| 67 | Abnormal social behavior (HP:0012433) | 2.45107859 |
| 68 | Impaired social interactions (HP:0000735) | 2.45107859 |
| 69 | Slender build (HP:0001533) | 2.43950875 |
| 70 | Ketoacidosis (HP:0001993) | 2.43694668 |
| 71 | Vertebral compression fractures (HP:0002953) | 2.43293111 |
| 72 | Fragile skin (HP:0001030) | 2.38540384 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.36919308 |
| 74 | Difficulty climbing stairs (HP:0003551) | 2.36791406 |
| 75 | Pheochromocytoma (HP:0002666) | 2.34837100 |
| 76 | Neck muscle weakness (HP:0000467) | 2.33718590 |
| 77 | Follicular hyperkeratosis (HP:0007502) | 2.33414507 |
| 78 | Abnormal atrioventricular conduction (HP:0005150) | 2.31722830 |
| 79 | Ketosis (HP:0001946) | 2.31688210 |
| 80 | Gingival bleeding (HP:0000225) | 2.31472461 |
| 81 | Cerebral aneurysm (HP:0004944) | 2.31284863 |
| 82 | Lipoatrophy (HP:0100578) | 2.28544633 |
| 83 | Failure to thrive in infancy (HP:0001531) | 2.28457760 |
| 84 | Epistaxis (HP:0000421) | 2.28359103 |
| 85 | Rapidly progressive (HP:0003678) | 2.27004499 |
| 86 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.26510904 |
| 87 | Supranuclear gaze palsy (HP:0000605) | 2.23986353 |
| 88 | Palpitations (HP:0001962) | 2.22708275 |
| 89 | Abnormal eating behavior (HP:0100738) | 2.22242849 |
| 90 | Achilles tendon contracture (HP:0001771) | 2.22200610 |
| 91 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.21932318 |
| 92 | Abnormal platelet function (HP:0011869) | 2.21080155 |
| 93 | Impaired platelet aggregation (HP:0003540) | 2.21080155 |
| 94 | Fetal akinesia sequence (HP:0001989) | 2.19794969 |
| 95 | Back pain (HP:0003418) | 2.15707223 |
| 96 | Lymphangioma (HP:0100764) | 2.13656472 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 2.13620885 |
| 98 | Type 1 muscle fiber predominance (HP:0003803) | 2.12194957 |
| 99 | Osteolytic defects of the hand bones (HP:0009699) | 2.11343757 |
| 100 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11343757 |
| 101 | Generalized amyotrophy (HP:0003700) | 2.11167042 |
| 102 | Subaortic stenosis (HP:0001682) | 2.11096055 |
| 103 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.11096055 |
| 104 | Shallow orbits (HP:0000586) | 2.10737613 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 2.09946952 |
| 106 | Hyperventilation (HP:0002883) | 2.09543057 |
| 107 | Mutism (HP:0002300) | 2.08747278 |
| 108 | Broad-based gait (HP:0002136) | 2.08454649 |
| 109 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06999796 |
| 110 | Aneurysm (HP:0002617) | 2.06321763 |
| 111 | Scapular winging (HP:0003691) | 2.06148911 |
| 112 | Depression (HP:0000716) | 2.05424274 |
| 113 | Cervical subluxation (HP:0003308) | 2.04399512 |
| 114 | Vascular calcification (HP:0004934) | 2.04226417 |
| 115 | Upper limb amyotrophy (HP:0009129) | 2.02774986 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 2.02774986 |
| 117 | Hyperlipoproteinemia (HP:0010980) | 2.02070020 |
| 118 | Gowers sign (HP:0003391) | 2.02027441 |
| 119 | Myocardial infarction (HP:0001658) | 2.01406321 |
| 120 | Torticollis (HP:0000473) | 2.01385352 |
| 121 | Distal arthrogryposis (HP:0005684) | 2.01091793 |
| 122 | Dysdiadochokinesis (HP:0002075) | 2.01070214 |
| 123 | Complement deficiency (HP:0004431) | 2.00828683 |
| 124 | Genetic anticipation (HP:0003743) | 2.00403816 |
| 125 | Polycythemia (HP:0001901) | 2.00392917 |
| 126 | Hemiplegia (HP:0002301) | 1.99954254 |
| 127 | Dilatation of the ascending aorta (HP:0005111) | 1.99526636 |
| 128 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.98739886 |
| 129 | Oligomenorrhea (HP:0000876) | 1.98733008 |
| 130 | Absence seizures (HP:0002121) | 1.98257352 |
| 131 | Xanthomatosis (HP:0000991) | 1.95643809 |
| 132 | Anxiety (HP:0000739) | 1.94928585 |
| 133 | Abnormal delivery (HP:0001787) | 1.94611455 |
| 134 | Drooling (HP:0002307) | 1.94443532 |
| 135 | Excessive salivation (HP:0003781) | 1.94443532 |
| 136 | Acanthosis nigricans (HP:0000956) | 1.93221119 |
| 137 | Epidermoid cyst (HP:0200040) | 1.93020544 |
| 138 | Muscle stiffness (HP:0003552) | 1.92587839 |
| 139 | Ulnar deviation of the wrist (HP:0003049) | 1.92109736 |
| 140 | Scanning speech (HP:0002168) | 1.91815456 |
| 141 | Hyperammonemia (HP:0001987) | 1.91081736 |
| 142 | Bladder diverticulum (HP:0000015) | 1.90695742 |
| 143 | Ankle clonus (HP:0011448) | 1.90639426 |
| 144 | EMG: neuropathic changes (HP:0003445) | 1.90542653 |
| 145 | Blue sclerae (HP:0000592) | 1.89611461 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.87806607 |
| 147 | Broad metatarsal (HP:0001783) | 1.87452442 |
| 148 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.85425782 |
| 149 | Hemorrhage of the eye (HP:0011885) | 1.85113763 |
| 150 | Popliteal pterygium (HP:0009756) | 1.81983863 |
| 151 | Cerebral hemorrhage (HP:0001342) | 1.80655454 |
| 152 | Dilated cardiomyopathy (HP:0001644) | 1.80557410 |
| 153 | Conjugated hyperbilirubinemia (HP:0002908) | 1.80499658 |
| 154 | Muscle fiber inclusion bodies (HP:0100299) | 1.80366690 |
| 155 | Hypertriglyceridemia (HP:0002155) | 1.80212366 |
| 156 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79861800 |
| 157 | Soft skin (HP:0000977) | 1.79164081 |
| 158 | Postural instability (HP:0002172) | 1.78908949 |
| 159 | Mitral valve prolapse (HP:0001634) | 1.78649864 |
| 160 | Hypoalphalipoproteinemia (HP:0003233) | 1.78357660 |
| 161 | Axonal loss (HP:0003447) | 1.77751015 |
| 162 | Obstructive sleep apnea (HP:0002870) | 1.77270136 |
| 163 | Dysmetria (HP:0001310) | 1.76973944 |
| 164 | Epileptic encephalopathy (HP:0200134) | 1.76287728 |
| 165 | Neonatal onset (HP:0003623) | 1.76097621 |
| 166 | Skin nodule (HP:0200036) | 1.76053767 |
| 167 | Urinary urgency (HP:0000012) | 1.75839657 |
| 168 | Atonic seizures (HP:0010819) | 1.75831152 |
| 169 | Abnormality of the corticospinal tract (HP:0002492) | 1.74574117 |
| 170 | Hyperglycinuria (HP:0003108) | 1.73377974 |
| 171 | Focal dystonia (HP:0004373) | 1.71104867 |
| 172 | Cerebral inclusion bodies (HP:0100314) | 1.70355469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 3.99351234 |
| 2 | PHKG1 | 3.11569443 |
| 3 | PHKG2 | 3.11569443 |
| 4 | NTRK3 | 2.88443901 |
| 5 | TIE1 | 2.33363357 |
| 6 | MAP2K4 | 2.31867336 |
| 7 | TESK1 | 2.27066712 |
| 8 | MAP3K9 | 2.26175938 |
| 9 | MAP3K4 | 2.25893858 |
| 10 | TGFBR2 | 2.18327945 |
| 11 | PTK2 | 2.10748392 |
| 12 | LMTK2 | 2.07320106 |
| 13 | MINK1 | 2.04155371 |
| 14 | LIMK1 | 2.03376400 |
| 15 | RIPK1 | 1.89653692 |
| 16 | DDR2 | 1.84668355 |
| 17 | DAPK2 | 1.84120540 |
| 18 | MET | 1.82877801 |
| 19 | NTRK2 | 1.81161849 |
| 20 | MOS | 1.78258922 |
| 21 | TRIB3 | 1.75736535 |
| 22 | PIK3CG | 1.72605133 |
| 23 | TTN | 1.69029906 |
| 24 | ARAF | 1.67199732 |
| 25 | PAK6 | 1.66067099 |
| 26 | MST1R | 1.65444087 |
| 27 | LATS2 | 1.62624895 |
| 28 | EPHA4 | 1.57643141 |
| 29 | EPHB1 | 1.52625307 |
| 30 | MAP2K7 | 1.50030994 |
| 31 | MAPKAPK3 | 1.48026598 |
| 32 | ERN1 | 1.45674831 |
| 33 | EPHA2 | 1.44174366 |
| 34 | PDK3 | 1.43378035 |
| 35 | PDK4 | 1.43378035 |
| 36 | BMX | 1.43285114 |
| 37 | MARK2 | 1.38139435 |
| 38 | MAP3K6 | 1.35135269 |
| 39 | PAK4 | 1.34748999 |
| 40 | KSR2 | 1.29503703 |
| 41 | IRAK3 | 1.28633068 |
| 42 | PAK3 | 1.28204576 |
| 43 | GRK5 | 1.27612177 |
| 44 | MAPK12 | 1.26813850 |
| 45 | MYLK | 1.22716159 |
| 46 | EPHB2 | 1.21692111 |
| 47 | OBSCN | 1.21614377 |
| 48 | NEK9 | 1.21284981 |
| 49 | STK38 | 1.20427123 |
| 50 | PINK1 | 1.18726150 |
| 51 | PRPF4B | 1.16863692 |
| 52 | TRPM7 | 1.15800168 |
| 53 | PAK2 | 1.15374092 |
| 54 | KSR1 | 1.13556706 |
| 55 | BCKDK | 1.11267606 |
| 56 | MAPK13 | 1.11212512 |
| 57 | CAMKK1 | 1.08333120 |
| 58 | FER | 1.07967053 |
| 59 | CAMK1G | 1.07190197 |
| 60 | PDGFRB | 1.04683665 |
| 61 | CDK5 | 1.03702275 |
| 62 | ILK | 1.02412967 |
| 63 | ABL2 | 1.01536737 |
| 64 | MAP3K3 | 1.00158714 |
| 65 | NTRK1 | 0.99613570 |
| 66 | RET | 0.99281207 |
| 67 | DMPK | 0.98952658 |
| 68 | SIK2 | 0.94408621 |
| 69 | MAP3K7 | 0.93917794 |
| 70 | PKN2 | 0.93446275 |
| 71 | MAP3K12 | 0.90581628 |
| 72 | PRKD2 | 0.90552645 |
| 73 | PIM2 | 0.88351755 |
| 74 | CAMK2A | 0.86480328 |
| 75 | DAPK3 | 0.85951846 |
| 76 | ERBB4 | 0.85650466 |
| 77 | ROCK2 | 0.85130028 |
| 78 | CAMK1 | 0.84527654 |
| 79 | PRKD3 | 0.84331065 |
| 80 | SIK1 | 0.83618626 |
| 81 | ZAP70 | 0.83394159 |
| 82 | LATS1 | 0.80566304 |
| 83 | PRKCH | 0.79512130 |
| 84 | PDK2 | 0.79099672 |
| 85 | PRKAA1 | 0.78017157 |
| 86 | NEK1 | 0.77789639 |
| 87 | CAMK4 | 0.76649549 |
| 88 | SGK3 | 0.75881228 |
| 89 | TAOK2 | 0.75358960 |
| 90 | MAP2K3 | 0.74280629 |
| 91 | CAMKK2 | 0.73989828 |
| 92 | SGK494 | 0.73087775 |
| 93 | SGK223 | 0.73087775 |
| 94 | PTK2B | 0.72961143 |
| 95 | FLT3 | 0.71792565 |
| 96 | MAP3K13 | 0.71388631 |
| 97 | TYRO3 | 0.70930832 |
| 98 | PRKCG | 0.70223070 |
| 99 | SGK2 | 0.70016517 |
| 100 | CAMK1D | 0.69908397 |
| 101 | TAOK1 | 0.68279344 |
| 102 | SIK3 | 0.66168963 |
| 103 | PKN1 | 0.65557692 |
| 104 | PRKD1 | 0.65426221 |
| 105 | STK11 | 0.64953488 |
| 106 | ADRBK1 | 0.63938621 |
| 107 | PDGFRA | 0.63528411 |
| 108 | ERBB3 | 0.63428394 |
| 109 | INSRR | 0.62226511 |
| 110 | MUSK | 0.61919153 |
| 111 | PRKG2 | 0.61396940 |
| 112 | MAP2K1 | 0.60659498 |
| 113 | CAMK2D | 0.60506353 |
| 114 | PDPK1 | 0.60354838 |
| 115 | ROCK1 | 0.58285351 |
| 116 | MAP3K1 | 0.57416583 |
| 117 | FGFR4 | 0.57182796 |
| 118 | CAMK2G | 0.57150768 |
| 119 | PRKCZ | 0.56775360 |
| 120 | ICK | 0.55613163 |
| 121 | PRKACG | 0.55397139 |
| 122 | PAK1 | 0.55291553 |
| 123 | RPS6KA2 | 0.55205682 |
| 124 | CDC42BPA | 0.55025444 |
| 125 | MAP3K2 | 0.54777137 |
| 126 | CAMK2B | 0.53994992 |
| 127 | DYRK2 | 0.53859205 |
| 128 | FES | 0.53849906 |
| 129 | GRK7 | 0.53771339 |
| 130 | BCR | 0.53725818 |
| 131 | TNIK | 0.53483414 |
| 132 | FGFR2 | 0.51787236 |
| 133 | PIK3CA | 0.51142047 |
| 134 | CDK18 | 0.51118390 |
| 135 | CDK14 | 0.50800238 |
| 136 | CSNK1G2 | 0.50594990 |
| 137 | UHMK1 | 0.50451006 |
| 138 | WNK1 | 0.50326275 |
| 139 | PRKAA2 | 0.49532904 |
| 140 | PRKCE | 0.48912728 |
| 141 | MAP2K6 | 0.48212063 |
| 142 | MAPK4 | 0.45732096 |
| 143 | MAP3K5 | 0.44978060 |
| 144 | PDK1 | 0.43849071 |
| 145 | GSK3A | 0.41995783 |
| 146 | MTOR | 0.41059360 |
| 147 | MAPK7 | 0.40532578 |
| 148 | SRC | 0.37506958 |
| 149 | PRKG1 | 0.33574461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.80303930 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.58690978 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.25309757 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06407873 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.04337542 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.03051360 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.95688697 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.83723986 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.82928799 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.79403811 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.76379709 |
| 12 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.74962268 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.70834346 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.68349080 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63223793 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.60856380 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60321543 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57665823 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.55686820 |
| 20 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.54274219 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.53321013 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52741406 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.51141620 |
| 24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50042951 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.47758362 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45373656 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43217867 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.41087409 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.39777917 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.33513240 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32450845 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31579538 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31197871 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.30503563 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.26308911 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.25686863 |
| 37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23726656 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.22938348 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.22204688 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.20322134 |
| 41 | Morphine addiction_Homo sapiens_hsa05032 | 1.20187747 |
| 42 | Insulin secretion_Homo sapiens_hsa04911 | 1.17268022 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.16933119 |
| 44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16562185 |
| 45 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.14415206 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.12926357 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12003743 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 1.11242726 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08381967 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07810831 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07114064 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06688465 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06444362 |
| 54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05937478 |
| 55 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.05068606 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.04755072 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04655704 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04009895 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03113282 |
| 60 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02144333 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.00825567 |
| 62 | Adherens junction_Homo sapiens_hsa04520 | 0.95272477 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94885609 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94747552 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94092104 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93303915 |
| 67 | * Axon guidance_Homo sapiens_hsa04360 | 0.92948443 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91950462 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.89681247 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.89381528 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89359539 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88790565 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86391755 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85362931 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84816992 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84566437 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.84019486 |
| 78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82769763 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81825401 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79464572 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77191680 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76991737 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76826589 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.74951423 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74481901 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72651386 |
| 87 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72074073 |
| 88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.70541309 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69521250 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69403604 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.69309857 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68649853 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.68232102 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68127444 |
| 95 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66718456 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.66264550 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65570866 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64860404 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64252002 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61880913 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61789962 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59116536 |
| 103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58974460 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58957198 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58552097 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.57813447 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.57023000 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56049465 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55545614 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55200196 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54942739 |
| 112 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54790894 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50222058 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49872517 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.48940555 |
| 116 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48262870 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47373202 |
| 118 | Melanogenesis_Homo sapiens_hsa04916 | 0.46355467 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45668619 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.45630757 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45079364 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44814602 |
| 123 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43641463 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43011404 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.42214281 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.42141099 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42059870 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42030390 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41886202 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41856600 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.41794206 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.41767628 |
| 133 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41513226 |
| 134 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41232365 |
| 135 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41225929 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40990362 |
| 137 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39007289 |
| 138 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38707046 |
| 139 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38346421 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37915556 |
| 141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.37682983 |
| 142 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37170511 |
| 143 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36769730 |

